MedTrace Logo

Effects of Virtual Reality and Tablet Distraction During IV Cannulation in Children

NCT07739381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2026-07-31

No results posted yet for this study

Summary

This randomized controlled trial was conducted to evaluate the effects of virtual reality and tablet-based audiovisual distraction on pain, anxiety, and fear in children undergoing intravenous cannulation in a pediatric emergency department. Children aged 7 to 12 years were randomly assigned to three groups: virtual reality, tablet, and control. During intravenous cannulation, children in the virtual reality group watched an entertaining video using a virtual reality headset, while children in the tablet group watched the same video on a tablet. Children in the control group received routine care without an audiovisual distraction intervention. Pain, anxiety, and fear were assessed using age-appropriate validated scales. The study compared the effects of the two distraction methods with routine care and with each other.

Conditions

Interventions

BEHAVIORAL

Virtual Reality Distraction

Children in the virtual reality group received virtual reality-based distraction during intravenous cannulation. A virtual reality headset was used to divert the child's attention from the procedure.

BEHAVIORAL

Tablet Distraction

Children in the tablet group watched an age-appropriate cartoon on a tablet during intravenous cannulation to divert their attention from the procedure.

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2022-08-01
Completion
2022-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07739381 on ClinicalTrials.gov